2024-25 Frederick L. Hovde Distinguished Lecturer

 

Thomas Fuchs, Dr.sc

Chief AI Officer, Eli Lilly

 

Spring 2025, Date and Time TBA

Bio

Thomas J. Fuchs, Dr.sc. is the chief AI officer Eli Lilly. He provides vision, strategic direction and overall leadership of AI initiatives across Lilly, including drug discovery, clinical trials, manufacturing, and commercial activities. Before joining Lilly, Fuchs was the dean and inaugural department chair for AI and Human Health at Mount Sinai, director of the Hasso Plattner Institute for Digital Health at Mount Sinai, and the endowed Barbara T. Murphy professor for AI and computational pathology at the Icahn School of Medicine at Mount Sinai. Prior, Fuchs held positions at Memorial Sloan Kettering Cancer Center, NASA's Jet Propulsion Laboratory and the California Institute of Technology, and founded three companies, including Paige AI. Fuchs holds a doctoral degree in machine learning from ETH Zurich and a master’s in technical mathematics from Graz Technical University in Austria.